1.09
-0.05(-4.39%)
Currency In USD
| Previous Close | 1.14 |
| Open | 1.14 |
| Day High | 1.17 |
| Day Low | 1.09 |
| 52-Week High | 2.75 |
| 52-Week Low | 1.01 |
| Volume | 109,739 |
| Average Volume | 219,023 |
| Market Cap | 8.1M |
| PE | -0.55 |
| EPS | -2 |
| Moving Average 50 Days | 1.47 |
| Moving Average 200 Days | 1.61 |
| Change | -0.05 |
If you invested $1000 in Intelligent Bio Solutions Inc. (INBS) since IPO date, it would be worth $0.41 as of October 08, 2025 at a share price of $1.09. Whereas If you bought $1000 worth of Intelligent Bio Solutions Inc. (INBS) shares 3 years ago, it would be worth $8.26 as of October 08, 2025 at a share price of $1.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance
GlobeNewswire Inc.
Sep 26, 2025 12:30 PM GMT
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
GlobeNewswire Inc.
Sep 17, 2025 12:30 PM GMT
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided an update on its FDA 51
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
GlobeNewswire Inc.
Aug 19, 2025 12:30 PM GMT
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growthNEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering